Explore evidence

0.609 ODIn the COVID-19 patient group, the median optical density (OD) for anti-S antibody was 0.609 (Q1; Q3: 0.333; 1.260) in males and 0.712 (Q1; Q3: 0.339; 1.193) in females.

MaliCOVID-19HAL · Unilimdocument of 67 observations

12 %Au Mali, la fréquence du trait drépanocytaire est située autour de 12 %.

MalidrépanocytoseHAL · Unilimdocument of 202 observations

70.5 %The protective efficacy of the combination as compared with chemoprevention alone was 70.5% against hospital admission with severe malaria according to the World Health Organization definition.

Malipaludismepublished 2021The New England journal of medicineeurope_pmcdocument of 10 observations

2.2 per_1000Long-lasting insecticidal net mass distribution reduced malaria incidence by 2.2 per 1000 for an adjusted coverage rate from 30.0 to 79.0%.

Malipaludismeobserved April 2017 to March 2022HAL · Unilimdocument of 111 observations

2.2 per_1000LLIN mass distribution was associated with a 2.2 ‰ reduction in malaria incidence in the general population of Mali.

MalipaludismeHAL · Unilimdocument of 111 observations

21.9 %A significant cross-reactive antibody response to S was detected in pre-COVID-19 and malaria samples at 21.9%.

MalipaludismeHAL · Unilimdocument of 67 observations

92.9 %The highest proportion of cerebral vasculopathy (92.9%) was observed in homozygous SCD patients.

Malicerebral vasculopathy · drépanocytosepublished 2013BloodOpenAlexdocument of 10 observations

95.22 %HemotypeSC® had a sensitivity of 95.22% to detect sickle cell disease carrier compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

100 %Tous les patients avec un test paludisme positif dans le bras intervention ont reçu un traitement : 372 sur 372 (100 %).

Malipaludismeobserved 2022HAL · Unilimdocument of 36 observations

15 joursLe temps requis pour la maturation et la libération des mérozoïtes des schizontes matures de P. malariae est d'environ 15 jours.

MalipaludismeHAL · Unilimdocument of 214 observations

31.58 per_1000En 2021, l'incidence du paludisme pendant la grossesse était de 31,58 pour 1000 femmes au Mali.

Malipaludismeobserved 2021HAL · Unilimdocument of 302 observations

351.06 per_1000_person_yearsThe median malaria incidence for the 5 epidemic years was 351.06 cases per 1,000 person-years.

MalipaludismeHAL · Unilimdocument of 111 observations

3.34 %Elevated AST was noted in 3.34% of treated malaria episodes.

Malipaludismepublished 2021Malaria journaleurope_pmcdocument of 14 observationsDOI 10.1186/s12936-021-03593-6

19 %La prévalence du paludisme dans ce groupe d’âge s’élevait à 19 % au Mali en 2018.

Malipaludismeobserved 2018HAL · Unilimdocument of 214 observations

200,000 parasites/μLL'hyper-parasitémie (≥200000 parasites par μL de sang) conduit au paludisme grave.

MalipaludismeHAL · Unilimdocument of 214 observations

18.3 %18.3% of mothers stated they would resort to self-medication in the event of discovered sickle cell disease.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

96.1 %The negative predictive value of OptiMal-IT compared to thick smear microscopy was 96.1%.

Malipaludismepublished 2011Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/1475-2875-10-345

96.1 %SickleScan® had a sensitivity of 96.10% to detect sickle cell disease carrier compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

66.8 %In a trial in Burkina Faso and Mali, the protective efficacy of RTS,S/AS01E combined with seasonal malaria chemoprevention (SMC) was 66.8% against death from malaria.

Burkina Faso · MalipaludismeHAL · Unilimdocument of 105 observations

3,771,426 casesIn 2023, the National Malaria Control Program in Mali recorded 3,771,426 clinical malaria cases.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

4 %In Côte d’Ivoire and its neighbouring countries (Ghana, Burkina Faso and Mali), the prevalence of sickle cell genetic traits is between 4% and 25%.

Burkina Faso · Ghana · MalidrépanocytoseHAL · Unilimdocument of 59 observations

251 cases_per_1000_person_yearsHealth districts with incidence rates between 251 and 450 cases per 1,000 person-years or Pf/Pv prevalence between 10% and 35% were classified as 'Moderate Transmission Zones'.

Malipaludisme · Pf/PvHAL · Unilimdocument of 95 observations

90 %P. falciparum représentait plus de 90 % des espèces plasmodiales détectées.

MalipaludismeHAL · Unilimdocument of 214 observations

Malaria incidence increased slightly in Mali between 2017 and 2022.

Malipaludismeobserved 2017–2022HAL · Unilimdocument of 111 observations

7.6 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 7.6% showed a 10-fold increase in anti-CSP IgG antibody titres post-2020 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2020HAL · Unilimdocument of 105 observations